policy+practice

Drug industry cash influences how doctors treat their patients.

The change could cut reimbursement for some of the best-selling drugs in America, in half, or more.

A new report provides a thorough analysis of the state of personalized oncology utilization across Europe.

Britain will pay individuals who suffer any severe side-effects from COVID-19 vaccines.

France will ensure free COVID-19 vaccinations for all in its social security system and has earmarked some 1.5 billion euros ($1.82 billion) of next year’s social security budget to cover the cost.

More than 60,000 people have now died in the UK after infection with coronavirus — one of the highest death rates in the world.

Former U.S. Presidents Barack Obama, George W. Bush and Bill Clinton said they were willing to be vaccinated against the novel coronavirus on television in order to ease any public skepticism over the safety of new vaccines.

UK NICE series of webinars discussing changes to process and methods for health technology evaluation.

The contracts are complicated and full of risks for drug companies. But there's also a risk to steering clear of the arrangements -- reduced or restricted access to a company's medication.

A participant in a COVID-19 vaccine trial has been sued for $13.5 million for defamation.

More than $2 billion a year was paid by pharma companies to doctors, fueling an increase in prescriptions.

The proposal, first described in an Advance Notice of Proposed Rulemaking (ANPRM) issued in 2018, was a primary focus of President Trump’s American Patients First Drug Pricing Blueprint and most recent Drug Pricing Executive Order.

The company is expected to release the results from the Phase I/II clinical trials this month.

The dean of the Brown University School of Public Health speaks to ABC News about the complexities of distributing the vaccine and the challenge of convincing people it’s safe to get.

White House press secretary Kayleigh McEnany says it is a "tremendous achievement" for the U.S. to have as many as 40 million vaccine doses ready by year’s end, crediting the accomplishment to President Donald Trump's background in the business world.